Spot Trading’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-720
Closed -$51K 3341
2017
Q1
$48K Buy
+720
New +$48K ﹤0.01% 2501
2016
Q4
Sell
-2,120
Closed -$138K 3041
2016
Q3
$150K Sell
2,120
-11,495
-84% -$838K ﹤0.01% 2247
2016
Q2
$1.01M Buy
13,615
+340
+3% +$23.5K 0.02% 1122
2016
Q1
$862K Buy
13,275
+11,290
+569% +$768K 0.02% 1197
2015
Q4
$153K Buy
1,985
+1,965
+9,825% +$156K ﹤0.01% 2612
2015
Q3
$2K Buy
+20
New +$1.78K ﹤0.01% 3786
2015
Q1
Sell
-2,028
Closed -$180K 4188
2014
Q4
$168K Buy
2,028
+331
+20% +$27.4K ﹤0.01% 3014
2014
Q3
$143K Sell
1,697
-2,806
-62% -$227K ﹤0.01% 3354
2014
Q2
$365K Sell
4,503
-30,230
-87% -$2.38M ﹤0.01% 2922
2014
Q1
$2.65M Buy
34,733
+34,681
+66,694% +$2.53M 0.01% 1278
2013
Q4
$4K Hold
52
﹤0.01% 3849
2013
Q3
$4K Hold
52
﹤0.01% 3980
2013
Q2
$3K Buy
+52
New +$3.38K ﹤0.01% 4084

Other funds holding NVS

Spot Trading's NVS Position: Q2 2017 in Review

Spot Trading sold out of Novartis (NVS) in Q2 2017, closing a stake of 720 shares — an estimated $51K sold.

Spot Trading first reported a position in NVS in Q2 2013 and held it in 13 quarters. The position peaked at $2.65M in Q1 2014. 921 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

  • Spot Trading reported no remaining Novartis position as of Q2 2017 after selling out during the quarter.
  • Spot Trading sold 720 Novartis shares in Q2 2017, an estimated $51K.
  • Spot Trading first reported a position in Novartis in Q2 2013 and held it in 13 quarters.
  • Spot Trading's Novartis position peaked at $2.65M in Q1 2014.
  • 921 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Spot Trading's 13F filing for Q2 2017, filed 27 Jul 2017.